NYSE:MRT - MedEquities Realty Trust Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$11.21 -0.08 (-0.71 %)
(As of 07/16/2018 01:04 AM ET)
Previous Close$11.21
Today's Range$11.21 - $11.36
52-Week Range$9.67 - $12.71
Volume63,269 shs
Average Volume139,184 shs
Market Capitalization$357.45 million
P/E Ratio9.58
Dividend Yield7.49%
MedEquities Realty Trust logoMedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment. For more information, please visit www.medequities.com.

Receive MRT News and Ratings via Email

Sign-up to receive the latest news and ratings for MRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Real estate investment trusts


Debt-to-Equity RatioN/A
Current Ratio7.65
Quick Ratio7.65


Trailing P/E Ratio9.58
Forward P/E Ratio9.34
P/E GrowthN/A

Sales & Book Value

Annual Sales$61.10 million
Price / Sales5.85
Cash Flow$1.1976 per share
Price / Cash9.36
Book Value$11.23 per share
Price / Book1.00


EPS (Most Recent Fiscal Year)$1.14
Net Income$20.42 million
Net Margins34.63%
Return on Equity6.17%
Return on Assets3.85%


Outstanding Shares31,890,000
Market Cap$357.45

The Truth About Cryptocurrencies

MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions

What is MedEquities Realty Trust's stock symbol?

MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT."

How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust?

MedEquities Realty Trust announced a quarterly dividend on Wednesday, May 9th. Investors of record on Tuesday, May 22nd will be given a dividend of $0.21 per share on Tuesday, June 5th. This represents a $0.84 annualized dividend and a yield of 7.49%. The ex-dividend date is Monday, May 21st. View MedEquities Realty Trust's Dividend History.

How were MedEquities Realty Trust's earnings last quarter?

MedEquities Realty Trust Inc (NYSE:MRT) announced its quarterly earnings results on Thursday, May, 10th. The financial services provider reported $0.16 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.30 by $0.14. The financial services provider earned $16.72 million during the quarter, compared to analyst estimates of $16.41 million. MedEquities Realty Trust had a return on equity of 6.17% and a net margin of 34.63%. View MedEquities Realty Trust's Earnings History.

When is MedEquities Realty Trust's next earnings date?

MedEquities Realty Trust is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for MedEquities Realty Trust.

What price target have analysts set for MRT?

7 brokerages have issued twelve-month target prices for MedEquities Realty Trust's stock. Their forecasts range from $10.00 to $14.00. On average, they anticipate MedEquities Realty Trust's share price to reach $12.2857 in the next year. This suggests a possible upside of 9.6% from the stock's current price. View Analyst Ratings for MedEquities Realty Trust.

What is the consensus analysts' recommendation for MedEquities Realty Trust?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

What are Wall Street analysts saying about MedEquities Realty Trust stock?

Here are some recent quotes from research analysts about MedEquities Realty Trust stock:
  • 1. Cantor Fitzgerald analysts commented, "MRT reported in-line 4Q17 results and issued 2018 guidance that includes fewer acquisitions than we modeled, and we believe could be conservative. Closings have been slower industry-wide, but the backlog of announced deals is good for 2018." (2/21/2018)
  • 2. According to Zacks Investment Research, "MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. " (1/3/2018)

Who are some of MedEquities Realty Trust's key competitors?

Who are MedEquities Realty Trust's key executives?

MedEquities Realty Trust's management team includes the folowing people:
  • Mr. John W. McRoberts, Chairman & CEO (Age 65)
  • Mr. William C. Harlan, Pres, COO & Director (Age 66)
  • Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 48)
  • Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 43)
  • Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC

When did MedEquities Realty Trust IPO?

(MRT) raised $259 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 19,900,000 shares at a price of $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers.

Has MedEquities Realty Trust been receiving favorable news coverage?

Media stories about MRT stock have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MedEquities Realty Trust earned a news sentiment score of 0.09 on Accern's scale. They also gave media coverage about the financial services provider an impact score of 45.51 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of MedEquities Realty Trust?

Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MedEquities Realty Trust's stock price today?

One share of MRT stock can currently be purchased for approximately $11.21.

How big of a company is MedEquities Realty Trust?

MedEquities Realty Trust has a market capitalization of $357.45 million and generates $61.10 million in revenue each year. The financial services provider earns $20.42 million in net income (profit) each year or $1.14 on an earnings per share basis. MedEquities Realty Trust employs 12 workers across the globe.

How can I contact MedEquities Realty Trust?

MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected]

MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  164 (Vote Underperform)
Total Votes:  302
MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.